Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 5, 2000, Pages 1002-1007

  Taha, Rame A ^a   Minshall, Eleanor M ^a   Leung, Donald Y M ^b   Boguniewicz, Mark ^b   Luster, Andrew ^c   Muro, Shigeo ^a   Toda, Masdo ^a   Hamid, Qutayba A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Atopic dermatitis; Chemokines; Eosinophils; Eotaxin; Lymphocytes; Monocyte chemotactic protein 4

Indexed keywords

EOTAXIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 4;

ADULT; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MACROPHAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0034079576     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.106483     Document Type: Article

References (28)

1. 1. Hanifin JM. Atopic dermatitis. J Allergy Clin Immunol 1984;73:211-26.
2. 2. Leung DY, Bhan AK, Schneeberger EE, Geha RS. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983;71:47-56.
3. 3. Garcia-Zepeda EA, Combadiere C, Rothenberg ME, et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996;157:5613-26.
4. 4. Heath H, Qin S, Rao P, et al. Chemokine receptor usage by human eosinophils: the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 1997;99:178-84.
5. 5. Rothenberg ME. Eotaxin: an essential mediator of eosinophil trafficking into mucosal tissues. Am J Respir Cell Mol Biol 1999;21:291-5.
6. 6. Yawalkar N, Uguccioni M, Scharer J, et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999;113:43-8.
7. 7. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-6.
8. 8. Ying S, Durham SR, Jacobson M, Rak S, et al. T lymphocytes and mast cells express for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:200-6.
9. 9. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988;141:4158-64.
10. 10. Taha RA, Minshall EM, Miotto D, et al. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 1999;103:476-83.
11. 11. Wright ED, Frenkiel S, Ghaffar O, et al. Monocyte chemotactic protein expression in allergy and non-allergy-associated chronic sinusitis. J Otolaryngol 1998;27:281-7.
12. 12. Christodoulopoulos P, Wright E, Frenkiel S, Luster A, Hamid Q. Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: effect of topical corticosteroids. J Allergy Clin Immunol 1999;103:1036-44.
13. 13. Lamkhioued B, Renzi PM, Abi-Younes S, et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:4593-601.
14. 14. Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17:683-90.
15. 15. Rollins BJ. Chemokines. Blood 1997;90:909-28.
16. 16. Sanz MJ, Ponath PD, Mackay CR, et al. Human eotaxin induces 4 and integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4. J Immunol 1998;160:3569-76.
17. 17. Jia GQ, Gonzalo JA, Hidalgo A, Wagner D, Cybulsky M, Gutierrez-Ramos JC. Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. Int Immunol 1999;11:1-10.
18. 18. Hohki G, Terada N, Hamano N, et al. The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells. Biochem Biophys Res Commun 1997;241:136-41.
19. 19. Kitayama J, Fuhlbrigge RC, Puri KD, et al. P-selectin, L-selectin, and alpha 4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. J Immunol 1997;159:3929-39.
20. 20. Tenscher K, Metzner B, Hofmann C, Schopf E, Norgauer J. The monocyte chemotactic protein-4 induces oxygen radical production, actin reorganization, and CD11b up-regulation via a pertussis toxin-sensitive G-protein in human eosinophils. Biochem Biophys Res Commun 1997;240:32-5.
21. 21. Robinson DS, North J, Zeibecoglou K, et al. Eosinophil development and bone marrow and tissue eosinophils in atopic asthma. Int Arch Allergy Immunol 1999;118:98-100.
22. 22. Palframan RT, Collins PD, Williams TJ, et al. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow: Blood 1998;91:2240-8.
23. 23. Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990;15:264-6.
24. 24. Lacy P, Moqbel R. Eokines: synthesis, storage and release from human eosinophils. Mem Inst Oswaldo Cruz 1997;92(2 Suppl):125-33.
25. 25. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A, Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-83.
26. 26. Ying S, Robinson DS, Meng Q, et al. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophila, and relationship to basophils and other C_C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 1999;163:3976-84.
27. 27. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:2005-7.
28. 28. Stellato C, Collins P, Ponath PD, et al. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 1997;99:926-36.